Trial Profile
Phase II study of the tolerability and efficacy of the histone deacetylase inhibitor sodium valproate [valproic acid] administered in conjunction with 5-azacitidine, theophylline and all trans-retinoic acid [tretinoin] in patients with acute myeloid leukaemia and high risk myelodysplasia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jun 2010
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary) ; Theophylline (Primary) ; Tretinoin (Primary) ; Valproic acid (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 16 Jun 2007 New trial record.